Asif Loya Selected Research

Asif Loya Research Topics

Disease

19	Neoplasms (Cancer) 11/2023 - 05/2012
9	Breast Neoplasms (Breast Cancer) 06/2021 - 04/2009
4	Carcinoma (Carcinomatosis) 08/2021 - 04/2009
3	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 05/2023 - 07/2018
2	Triple Negative Breast Neoplasms 01/2023 - 12/2020
2	Lymphoma (Lymphomas) 01/2022 - 04/2015
2	COVID-19 01/2021 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 07/2016
2	Lymphatic Metastasis 04/2015 - 04/2009
1	Astrocytoma (Pilocytic Astrocytoma) 04/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2023
1	Rheumatic Diseases (Rheumatism) 01/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2022
1	Necrosis 03/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2022
1	Papillomavirus Infections 04/2021
1	Sarcoma (Soft Tissue Sarcoma) 02/2021
1	Mesenchymal Chondrosarcoma 02/2021
1	Adenocarcinoma 02/2021
1	Residual Neoplasm 01/2020
1	Familial Breast Cancer 07/2019
1	Infections 07/2016
1	Neoplasm Metastasis (Metastasis) 10/2015
1	Lymphadenopathy 04/2015
1	Melanoma (Melanoma, Malignant) 12/2014
1	Nevus (Nevi) 06/2013
1	Intradermal Nevus 06/2013
1	Leishmaniasis 03/2012
1	Mucoepidermoid Carcinoma 09/2010
1	Pathologic Complete Response 04/2009
1	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2006
1	Papillary Carcinoma 03/2006
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2003
1	Hyperhomocysteinemia 07/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2003

Drug/Important Bio-Agent (IBA)

6	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2023 - 01/2019
5	EnzymesIBA 01/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2016
3	Progesterone Receptors (Progesterone Receptor)IBA 11/2023 - 11/2019
3	Formaldehyde (Formol)FDA Link 01/2023 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2012
3	ParaffinIBA 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 03/2022 - 01/2019
2	Estrogen ReceptorsIBA 12/2020 - 11/2019
2	Vitamin D FDA LinkGeneric 01/2015 - 05/2012
1	iodoxamic acid (BC 17)IBA 11/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2023
1	AutoantibodiesIBA 01/2023
1	RibonucleoproteinsIBA 01/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 12/2020
1	Hormones (Hormone)IBA 12/2020
1	LectinsIBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Galectin 3 (LGALS3)IBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2019
1	human ERBB2 proteinIBA 11/2019
1	Nonsense Codon (Nonsense Mutation)IBA 07/2019
1	GlypicansIBA 07/2018
1	Coloring Agents (Dyes)IBA 07/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2016
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 07/2014
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 06/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2010
1	PlacebosIBA 07/2003
1	Serine (L-Serine)FDA Link 07/2003
1	Vitamin B Complex (B Vitamins)IBA 07/2003
1	VitaminsIBA 07/2003
1	Leucovorin (Folinic Acid)FDA Link 07/2003
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2003

Therapy/Procedure

6	Therapeutics 01/2022 - 07/2003
2	Drug Therapy (Chemotherapy) 01/2020 - 04/2009
1	Immunotherapy 05/2023
1	Stents 01/2022
1	Chemoradiotherapy 08/2021
1	Adjuvant Radiotherapy 08/2021
1	N95 Respirators 10/2020
1	Personal Protective Equipment 10/2020
1	Ligation 01/2017
1	Adrenalectomy 10/2015
1	Laparotomy 10/2015
1	Aftercare (After-Treatment) 04/2015
1	Adjuvant Chemotherapy 11/2013
1	Segmental Mastectomy (Lumpectomy) 03/2006
1	Renal Dialysis (Hemodialysis) 07/2003